have the pfizer anti-viral, which show tremendous promise, decreasing hospitalizations by 89%. are you kidding me? we re not pushing that? that should be an emergency. we should get that out. when people do test positive, we have something to do. what s holding it up. you ve been in the private sector and also in government. what holds something like this up. well, when i was on the controversy task force, there was a sense of urgency. i don t see that sense of urgency now. why aren t they really anxious to get it under control? and you know, think about it, if we were so afraid of this virus, if this administration were so afraid of it, why are they letting people come through the southern border, 20% of whom are infected. there s a lot of stuff that
that really makes covid a much more treatable infection. much more like many of the other reps viruses we deal with. testing is really important. you ve got a window of opportunity for that drug to be effective. if a person is driving around town looking for a test to be able to be prescribed the pfizer anti-viral, that s going to completely eliminate the benefit. we have to make sure testing is in place and the infrastructure is there so we can actually utilize the great drug that science has given us. and we re also hearing, doctor, that some hospitals, i ve heard of in new york and also in d.c. are running out of the antibody treatments, and this takes a long time to make. i think it s i thought it was that s concerning that there are backlogs. definitely. we had three antibody products on the market. when the omicron variant appeared, we quickly learned some antibodies don t work